| scholarly article | Q13442814 |
| P2093 | author name string | Chien-Liang Liu | |
| Tsang-Pai Liu | |||
| Shih-Ping Cheng | |||
| Yi-Chiung Hsu | |||
| Jie-Jen Lee | |||
| P2860 | cites work | A new equation to estimate glomerular filtration rate | Q24651973 |
| Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review | Q26823409 | ||
| Klotho, phosphate and inflammation/ageing in chronic kidney disease | Q27013965 | ||
| Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor | Q28571343 | ||
| Role of blood platelets in infection and inflammation | Q33344923 | ||
| Red cell distribution width and mortality in older adults: a meta-analysis | Q33654608 | ||
| Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue | Q33940609 | ||
| Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality | Q57391136 | ||
| Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated? | Q57705020 | ||
| Inhibition of Human Platelet Aggregation by Parathyroid Hormone | Q57705026 | ||
| Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6 | Q58681737 | ||
| Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes | Q58681791 | ||
| Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study | Q59299922 | ||
| Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis | Q69354510 | ||
| Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study | Q71652194 | ||
| Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans | Q73397174 | ||
| Effect of parathyroid adenoma excision on interleukin-6 (IL-6) and IL-2 receptor levels | Q73484119 | ||
| Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism | Q73765409 | ||
| The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer | Q81151072 | ||
| Dietary-induced hyperparathyroidism affects serum and gingival proinflammatory cytokine levels in rats | Q82442761 | ||
| Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism | Q82932930 | ||
| Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction | Q83785790 | ||
| Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers | Q84142295 | ||
| A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study | Q84493586 | ||
| Effects of Parathyroid Hormone on Immune Function | Q34155707 | ||
| Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer | Q34228351 | ||
| Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. | Q34630666 | ||
| Fibroblast growth factor 23 and Inflammation in CKD | Q36067879 | ||
| Red blood cell distribution width and mortality risk in a community-based prospective cohort. | Q36070307 | ||
| 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study | Q36361339 | ||
| Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study | Q37101306 | ||
| What symptom improvement can be expected after operation for primary hyperparathyroidism? | Q37415472 | ||
| Parathyroid hormone, a uremic toxin | Q37587286 | ||
| FGF23 and PTH--double agents at the heart of CKD. | Q37996937 | ||
| Can parathyroid hormone be used as a biomarker for heart failure? | Q38033097 | ||
| The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. | Q38045094 | ||
| High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? | Q38111123 | ||
| Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients | Q39985011 | ||
| Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. | Q43271245 | ||
| Plasma parathyroid hormone and the risk of cardiovascular mortality in the community | Q43526388 | ||
| Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer | Q44401775 | ||
| Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism | Q45407060 | ||
| Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism | Q46058239 | ||
| Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults | Q46058943 | ||
| Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism | Q46222471 | ||
| Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients | Q46228296 | ||
| Secondary hyperparathyroidism promotes the acute phase response -- a rationale for supplemental vitamin D in prevention of vascular events in the elderly | Q46393991 | ||
| Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents | Q46527118 | ||
| Inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism | Q46672049 | ||
| Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study | Q46675443 | ||
| Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism | Q48707820 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 709024 | |
| P577 | publication date | 2014-03-23 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Association between parathyroid hormone levels and inflammatory markers among US adults | |
| P478 | volume | 2014 |
| Q89818879 | Association between Serum Calcium and Risk of Cardiometabolic Disease among Community-dwelling Adults in Taiwan |
| Q92276931 | Association between neutrophil-to-lymphocyte ratio and parathyroid hormone in patients with primary hyperparathyroidism |
| Q58702573 | Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion |
| Q50327504 | Association of admission serum levels of vitamin D, calcium, Phosphate, magnesium and parathormone with clinical outcomes in neurosurgical ICU patients. |
| Q49060418 | Association of low vitamin D levels with metabolic syndrome in hemodialysis patients |
| Q93347468 | Biochemical changes associated with temporomandibular disorders |
| Q37497197 | Both immune hormone IL-10 and parathormone tend to increase in serum of old osteoporotic people independently of 1, 25 dihydroxy vitamin D3 |
| Q88702526 | Combined deficiencies of 25-hydroxyvitamin D and anemia in preschool children with severe early childhood caries: A case-control study |
| Q41685533 | Dietary phosphate exacerbates intestinal inflammation in experimental colitis |
| Q49926607 | Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice. |
| Q93022172 | Increasing Age Hinders the Decline in B-Type Natriuretic Peptide Following Parathyroidectomy in Dialysis Patients |
| Q38942965 | Ironing out the cross talk between FGF23 and inflammation |
| Q34713301 | Negative association between serum parathyroid hormone levels and urinary perchlorate, nitrate, and thiocyanate concentrations in U.S. adults: the National Health and Nutrition Examination Survey 2005-2006 |
| Q53789736 | Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor. |
| Q59132558 | Redox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D |
| Q90455636 | Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study |
| Q49172009 | The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma |
| Q37205499 | Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study |
| Q47214050 | Vitamin D, parathyroid hormone and metabolic syndrome - the PORMETS study |
| Q47169224 | Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial. |
Search more.